The MEA synthetic biology market is expected to grow from US$ 698.02 million in 2021 to US$ 2,407.31 million by 2028; it is estimated to grow at a CAGR of 19.3% from 2021 to 2028.

Significant advancements have been seen in CRISPR-based technologies. In addition, significant funds and investments by leading synthetic biology companies continue to drive the shift in the major application of synthetic biology offerings from the textile industry to the pharmaceuticals industry. For instance, the proposal for the first clinical trials of CRISPR-based therapeutics for treating inherited diseases has been submitted to regulators, which is focused on gene editing therapy for beta-thalassemia and sickle cell disease. The most attractive targets for CRISPR-based gene therapy are genetic diseases arising from mutations. Another trend in the field of synthetic biology is set by Bolt Threads as the company has manufactured the first garment from spider silk, which is available commercially. The silk was produced by using gene-editing techniques. Further, as per the Twist Bioscience news, Spiber, a company, has collaborated with The North Face to produce a parka, which is a coat made up of ersatz spider silk. The company is yet to begin the sales of the coat, as it hasn’t worked out the cost of the coat. Such advancements in techniques and products are giving rise to new trends in the synthetic biology market, which are likely to drive the market growth in the coming years.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA synthetic biology market . The MEA synthetic biology market is expected to grow at a significant CAGR during the forecast period.

MEA Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

MEA Synthetic Biology Market Segmentation

The MEA synthetic biology market is analyzed based on products, technology, application, and country. Based on products, the market is segmented into enzymes, chassis organisms, oligonucleotides, and xeno-nucleic acids. The oligonucleotides segment dominated the market in 2020 and is expected to be fastest growing during the forecast period. Based on technology, the market is segmented into measurement & modeling, cloning & sequencing, genome engineering, gene synthesis, nanotechnology, and others. The gene synthesis segment dominated the market in 2020, while the genome engineering segment is expected to be fastest growing during the forecast period. Based on application, the market is segmented into medical applications, industrial applications, food and agriculture, environmental applications, and others. The medical applications segment dominated the market in 2020 and is expected to be fastest growing during forecast period. The MEA synthetic biology market is segmented into Saudi Arabia, UAE, South Africa, and Rest of MEA.

Agilent Technologies, Inc.; Amyris; Codexis; Genscript Biotech corporation; Integrated DNA Technologies; Merck KGaA; New England Biolabs; Novozymes A/S; Thermo Fisher Scientific; and Twist Bioscience are among the leading companies in the MEA synthetic biology market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Synthetic Biology Market – By Product
1.3.2 MEA Synthetic Biology Market – By Technology
1.3.3 MEA Synthetic Biology Market – By Application
1.3.4 MEA Synthetic Biology Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Synthetic Biology Market – Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Synthetic Biology Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Investments in Synthetic Biology
5.1.2 Rising Number of Start-Ups
5.2 Key Market Restraints
5.2.1 Renewed Regulations for Biotechnology
5.3 Key Market Opportunities
5.3.1 Collaboration Between Companies
5.4 Future Trends
5.4.1 Advanced Synthetic Biology
5.5 Impact Analysis
6. Synthetic Biology Market– MEA Analysis
6.1 MEA Synthetic Biology Market Revenue Forecast and Analysis
7. MEA Synthetic Biology Market Analysis – By Product
7.1 Overview
7.2 MEA Synthetic Biology Market, By Product, 2021 & 2028 (%)
7.3 Enzymes
7.3.1 Overview
7.3.2 Enzyme: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Oligonucleotides
7.4.1 Overview
7.4.2 Oligonucleotide: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Chassis Organisms
7.5.1 Overview
7.5.2 Chassis Organisms: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Xeno-Nucleic Acids
7.6.1 Overview
7.6.2 Xeno-Nucleic Acids: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)
8. MEA Synthetic Biology Market Analysis – By Technology
8.1 Overview
8.2 MEA Synthetic Biology Market Share by Technology – 2021 & 2028 (%)
8.3 Gene Synthesis
8.3.1 Overview
8.3.2 Gene Synthesis: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.4 Genome Engineering
8.4.1 Overview
8.4.2 Genome Engineering: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.5 Measurement and Modeling
8.5.1 Overview
8.5.2 Measurement and Modeling: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.6 Cloning and Sequencing
8.6.1 Overview
8.6.2 Cloning and Sequencing: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.7 Nanotechnology
8.7.1 Overview
8.7.2 Nanotechnology: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9. MEA Synthetic Biology Market Analysis – By Application
9.1 Overview
9.2 MEA Synthetic Biology Market Share by Application – 2021 & 2028 (%)
9.3 Medical Applications
9.3.1 Overview
9.3.2 Medical Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.3.2.1 Drug Discovery and Therapeutics
9.3.2.1.1 Overview
9.3.2.1.2 Drug Discovery and Therapeutics: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.3.2.2 Pharmaceuticals
9.3.2.2.1 Overview
9.3.2.2.2 Pharmaceuticals: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.4 Industrial Applications
9.4.1 Overview
9.4.2 Industrial Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.5 Food & Agriculture
9.5.1 Overview
9.5.2 Food & Agriculture: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.6 Environmental Applications
9.6.1 Overview
9.6.2 Environmental Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)
10. MEA Synthetic Biology Market – Country Analysis
10.1 MEA: Synthetic Biology Market
10.1.1 Overview
10.1.2 MEA: Synthetic Biology Market, by Country, 2021 & 2028 (%)
10.1.2.1 Saudi Arabia: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 Overview
10.1.2.1.2 Saudi Arabia: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 Saudi Arabia: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
10.1.2.1.4 Saudi Arabia: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
10.1.2.1.5 Saudi Arabia: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
10.1.2.1.6 Saudi Arabia: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
10.1.2.2 UAE: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Overview
10.1.2.2.2 UAE: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 UAE: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
10.1.2.2.4 UAE: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
10.1.2.2.5 UAE: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
10.1.2.2.6 UAE: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
10.1.2.3 South Africa: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Overview
10.1.2.3.2 South Africa: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 South Africa: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
10.1.2.3.4 South Africa: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
10.1.2.3.5 South Africa: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
10.1.2.3.6 South Africa: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
10.1.2.4 Rest of MEA: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.1 Overview
10.1.2.4.2 Rest of MEA: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3 MEA: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
10.1.2.4.4 MEA: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
10.1.2.4.5 MEA: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
10.1.2.4.6 MEA: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Agilent Technologies, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 MERCK KGaA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 New England Biolabs
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Integrated DNA Technologies
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Twist Bioscience
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 GenScript Biotech Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Novozymes A/S
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Codexis
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Amyris Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1. MEA Synthetic Biology Market, Revenue and Forecast, 2019–2028 (US$ Mn)
Table 2. Saudi Arabia: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
Table 3. Saudi Arabia: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
Table 4. Saudi Arabia: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
Table 5. Saudi Arabia: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
Table 6. UAE: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
Table 7. UAE: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
Table 8. UAE: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
Table 9. UAE: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
Table 10.   South Africa: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
Table 11.   South Africa: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
Table 12.   South Africa: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
Table 13.   South Africa: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
Table 14.   MEA: Synthetic Biology Market, by Product, 2019–2028 (USD Million)
Table 15.   MEA: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)
Table 16.   MEA: Synthetic Biology Market, by Application, 2019–2028 (USD Million)
Table 17.   MEA: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)
Table 18.   Organic Developments
Table 19.   Inorganic Developments
Table 20.   Glossary of Terms
 
 

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA synthetic biology market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the MEA synthetic biology market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the synthetic biology market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – Middle East and Africa Synthetic Biology Market

● Agilent Technologies, Inc.
● Amyris
● Codexis
● Genscript Biotech corporation
● Integrated DNA Technologies
● Merck KGaA
● New England Biolabs
● Novozymes A/S
● Thermo Fisher Scientific
● Twist Bioscience